FDA/CDC
FDA/CDC
Cost led to missed care for 4.5% of Americans in 2017
Steady decline in national rate appears to have halted.
FDA/CDC
Obesity didn’t just happen overnight
Data seem to suggest that exercise makes Americans gain weight.
FDA/CDC
Generic versions of Suboxone approved for opioid dependence
The FDA says patients who receive medication-assisted treatment for opioid use disorder reduce their risk of death from all causes by 50%.
FDA/CDC
CDC warns of hepatitis A outbreaks in injection drug users
Gap in vaccine availability now has been solved.
FDA/CDC
Suicides up 30%; risk factors go beyond diagnosed disorders
FDA/CDC
FDA effort focuses on approving more generic drugs
Changes to how REMS are written for generic drugs could bring more to market.
FDA/CDC
FDA advisory panelists reject Buvaya for acute pain
HYATTSVILLE, MD. – The 18-1 vote against the buprenorphine sublingual spray for moderate to severe pain is based on concerns about side effects....
FDA/CDC
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
FDA/CDC
FDA queries more companies about youth e-cig use
Action targets companies that make small, concealable vaping devices that kids think are cool.
FDA/CDC
Bipolar and seizure medication linked with serious immune system reaction
Lamotrigine will carry a warning about hemophagocytic lymphohistiocytosis.
FDA/CDC
CDC: Marijuana use may spur industries to rethink current policies
A new report from the CDC clears some of the smoke around marijuana use.